TP53 and hepatocellular carcinoma: Moreover, mutations of TP53 and CTNNB1 are the most prevalent molecular abnormalities in Hepatocellular carcinoma, which are mutually exclusive and define high- and low-risk groups characterized by different phenotypes [34].